Kathryn E Falberg insider trades
Open-market stock purchases and sales by Kathryn E Falberg, Director at Arcus Biosciences, Inc, from SEC Form 4 filings since Mar 8, 2010.
Track record: 69% of 16 scored buys are up 5% or more since purchase, averaging +140%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 11, 2026 | RCUS Arcus Biosciences, Inc | Bought (not open market) | — |
| Jun 11, 2026 | RCUS Arcus Biosciences, Inc | Bought (not open market) | — |
| May 21, 2026 | NUVB Nuvation Bio Inc | Bought (not open market) | — |
| Mar 23, 2026 | TTD Trade Desk, Inc | Sold (not open market) | — |
| Mar 23, 2026 | TTD Trade Desk, Inc | Sold (not open market) | $17.5K |
| Mar 23, 2026 | TTD Trade Desk, Inc | Sold (not open market) | $12.5K |
| Mar 5, 2026 | TTD Trade Desk, Inc | Sold | $1.5M |
| Mar 5, 2026 | TTD Trade Desk, Inc | Sold | $3.1M |
Companies traded
- RCUS Arcus Biosciences, Inc: 7 buys, last Jun 11, 2026
- NUVB Nuvation Bio Inc: 4 buys, last May 21, 2026
- TTD Trade Desk, Inc: 5 buys, 25 sales, last Mar 23, 2026
- TCDA Tricida, Inc: 1 buy, last Jun 15, 2022
- URGN UroGen Pharma Ltd: other filings, last Jun 7, 2021
- AIMT Aimmune Therapeutics, Inc: 2 buys, last Oct 13, 2020
- AXON Axovant Sciences Ltd: 1 buy, last May 15, 2017
- MDVN Medivation, Inc: 4 buys, last Sep 28, 2016
- BMRN Biomarin Pharmaceutical Inc: other filings, last Jul 15, 2016
- LIFE aTYR PHARMA Inc: other filings, last May 24, 2016
- HALO Halozyme Therapeutics Inc: 3 buys, last May 4, 2016
- JAZZ Jazz Pharmaceuticals plc: 3 buys, 10 sales, last Mar 5, 2014